A loving mother of four is granted the legal right for medical use of magic mushrooms. She then embarks on a remarkable journey of personal transformation and healing while exploring lesser known possible cures for cancer, like cannabis oil. This story of courage and resilience calls into question everything we think we know about the human body, mind, and spirit.

'DOSED: The Trip of a Lifetime' features: Dr Gabor Maté, Paul Stamets, Dennis McKenna, Dave Phillips, Sharan Sidhu, Ben Lightburn, Chino Julian, Garyth Moxey, Dr Rob Sealey, Dana Larsen, Tyler Chandler, Nicholas Meyers, and Laurie and Glenn Brooks.

Q&A panel will feature Dr. Arsalan Azam and Dr. Amanda Elowyn Khan.

Dr. Arsalan Azam is a board-certified Emergency Medicine physician and medical director. During his time as a physician, Dr. Azam has dealt with numerous psychiatric emergencies and wanted to do more to help his patients. This inspired him to start Daydream MD to provide affordable, effective, state-of-the-art psychedelic and mental health solutions to his community. Daydream MD is committed to innovating new models of care for psychedelic-assisted therapy and integration, with a focus on reducing costs to maximize accessibility.

Dr. Amanda Elowyn Khan (she/they) is a licensed clinical psychologist in private practice and at Sage Integrative Health, a holistic psychedelic clinic in the Bay Area. In both her private practice and at Sage, Dr. Khan provides relational somatic psychotherapy, ketamine-assisted psychotherapy, and psychedelic integration. She also serves as lead psilocybin therapist on the UCSD randomized controlled trial for phantom limb pain. Dr. Khan specializes in the assessment and treatment of trauma, PTSD, and anxiety and depression-related disorders. She completed her residencies and postdoctoral fellowships at the San Francisco VA, UCSF, and UCSD. Dr. Khan completed Ketamine-Assisted Psychotherapy training with Polaris Insight, MDMA-Assisted Therapy training with MAPS, and the yearlong UC-Berkeley Advanced Psychedelic Facilitation Training Program. Dr. Khan conducted diagnostic assessments for the MAPS MDMA-assisted therapy for PTSD phase 2 and phase 3 trials for 4 years. She currently serves as Contributing Editor for the Trauma & Diversity column of ISTSS Stress Points. She also supervises psychedelic therapists in training and conducts research on moral injury, PTSD, and psychedelic therapy.